Clinical Diagnostics with Cerebra Sleep System

Revolutionizing Sleep Diagnostics at Home

Cerebra Sleep System is revolutionizing clinical sleep diagnostics by bringing truly self-applied, full polysomnography (PSG) capability to the home; allowing you to gain a true understanding of what happens during sleep using Odds Ratio Product (ORP) - a highly validated measure of sleep depth.

Measures Sleep Quality and Depth

Cerebra Sleep System measures sleep depth. With Sleep Apnea, the Cerebra Sleep System measures sleep and as a result, a true measure of sleep apnea events per hour can be made leading to accurate diagnosis, improved treatment, and patient affordability. Home Sleep Apnea Tests (HSAT) are useful screening tools but unlike Cerebra’s Sleep System, HSAT does not measure sleep quality. This can underestimate the severity of sleep apnea and miss crucial information on sleep depth and sleep quality. Unfortunately, this underestimation can lead to adverse patient outcomes, and it undermines the importance of putting the “sleep” into sleep medicine.

Cerebra Sleep System is an easy-to-use cloud platform that allows for remote data upload, equipment management, sleep study scheduling, study results and production of patient reports.

Cerebra Sleep System using Odds Ratio Product (ORP) as a measure of sleep depth is superior to HSAT and a preferred technology in critical diagnosis and study for a patient’s sleep health.

  • In-home PSG detected 4.4 more respiratory events per hour than HSAT.
  • 14.2% of In-home PSG patients were classified as moderate OSA who would have been classified as mild OSA with HSAT.
  • Since most health insurance providers require an AHI>15 to receive CPAP coverage, using in-home PSG resulted in an increase of 40% of treatable patients.

 

Become a Partner >

  • Note: HSAT was "simulated" in that it was the same sleep recording as the in-home PSG with the EEG removed (not including RERAs and using TRT instead of TST). Criteria for respiratory events were based on a 3% desaturation threshold using RDI for In-Home PSG vs AHI for HSAT.

Case Study #2: In-home PSG vs. HSAT Diagnosis

“Neil” a 38-year-old male was referred for a sleep study after suffering from poor sleep and complaints of insomnia for years.


Neil completed an at-home PSG using the Cerebra Sleep System, where sleep apnea was ruled out as Neil’s apnea-hypopnea index (AHI) was 3.4, indicating no sleep apnea. Cerebra Sleep System measures EEG, which enables a better understanding of how breathing affects sleep using respiratory disturbance index (RDI). Neil’s RDI was 6.2 which is considered mild. So, what is causing Neil’s sleep issues? Here’s where the unique benefit of the Cerebra Sleep System became apparent.

Cerebra Sleep System is a Class 2 medical device that is cleared for clinical use by Health Canada and the US Food and Drug Administration.